Vivek Seigell, Sr VP, Corporate Affairs, Apeejay Stya Svran Group, Author at Express Pharma - Page 75 of 1176

U.S. Tariffs on India’s pharma: Who pays, what’s at risk

Pfizer launches Pneumococcal Conjugate Vaccine for adults in India

Eyestem Research raises $10 million to advance Eyecyte-RPE cell therapy for dry AMD

Zydus receives USFDA approval for Diltiazem Hydrochloride Tablets in multiple strengths

AbbVie’s upadacitinib holds potential to cement dominant place in alopecia areata with latest results: GlobalData

Lupin launches Glucagon for injection USP in the United States

Can we reduce plastics usage in pharmaceutical industry? – Think

Zydus Lifesciences receives Health Canada approval for smoking cessation drug

QRL Bioscience raises ₹3 crore from GVFL to advance regenerative therapies

Industry experts weigh in on US tariff exemption for Indian pharma amid section 232 review